Nanoveu Ltd. · ASX:NVU

Nanoveu — Broker Briefing – Tech and Biotech Investor Webinar (September 2021)

14 slides from Nanoveu's conference presentation, Sep 9, 2021

  1. Slide 1: Investor Webinar Presentation ASX Release

    Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com For personal use only ASX RELEASE 9 September 2021 ASX: NVU Investor Webinar Presentation Nanoveu Limited (“Nanoveu”) participated in the Broker Briefing – Tech and Biotech Investor Webinar held on Thursday 9 Septemb

  2. Slide 2: Broker Briefing | Tech and Biotech Investor Webinar

    For personal use only BROKER BRIEFING | TECH AND BIOTECH INVESTOR WEBINAR 9 SEPTEMBER 2021 (ASX:NVU)

  3. Slide 3: Disclosure and Disclaimer

    DISCLOSURE AND DISCLAIMER For personal use only ¡ The information in this presentation has been prepared by Nanoveu for the purposes of providing an overview of the company and its products. ¡ This presentation does not constitute investment advice. Neither does this presentation nor the information

  4. Slide 4: Company Overview

    COMPANY OVERVIEW For personal use only ¡ Incorporated in 2012, IPO in Nov 2018 ¡ Collaboration with ASTAR and NTU – in Singapore for its R&D ¡ Experts in harnessing nano-technology to solve major problems, including anti-viral digital screen protection ¡ Revolutionary anti-viral digital device prote

  5. Slide 5: Highly Experienced Board and Management

    HIGHLY EXPERIENCED BOARD AND MANAGEMENT For personal use only Alfred Chong Steven Apedaile Executive Chairman & Chief Executive Officer Non-executive Director § Serial technology entrepreneur and founder of § Approximately 30 years’ experience in international Nanoveu business, corporate finance and

  6. Slide 6: Product Development Timeline

    PRODUCT DEVELOPMENT TIMELINE For personal use only 2017 2020 EyeFly3D phone screen protector launched with ability to produce 3D 2021 graphics on devices Nanoshield™, without SD glasses developed and launched in early 2020, 2022 We are continuing to with manufacturing CustomSkins lamination review t

  7. Slide 7: Benefits of Nanoshield

    BENEFITS OF NANOSHIELD™ For personal use only MADE IN PET Film –Visible Advanced Optical clarity Easy installation Lab tested with in antiviral manufacturing for touchscreens with a variety of Singapore, USA, Australia, protection in Japan – made with plastic options – India, China, Japan and nano m

  8. Slide 8: Independent Testing Proves Technology Works

    INDEPENDENT TESTING PROVES TECHNOLOGY WORKS For personal use only Nanoshield™ Technology has been independently tested against selected bacteria and viruses in accordance with the relevant ISO standards1. 1. See ASX Announcements of 15 April 2020, 5 May 2020, 25 May 2020, 18 February 2021 and 28 Jul

  9. Slide 9: Nanoshield Film Solution is Visible and Proven

    NANOSHIELDTM FILM SOLUTION IS VISIBLE AND PROVEN For personal use only * See ASX Announcements of 15 April 2020, 5 May 2020, 25 May 2020, 18 February 2021 and 28 July 2021 for the testing performed and the results. 8

  10. Slide 10: Sales Development

    SALES DEVELOPMENT For personal use only Nanoshield™ Distributors and Sales Networks ¡ Expanding list of international distributors ¡ Capital efficient method to accelerate sales ¡ Capitalises on international demand for intuitive antiviral protection ¡ Exclusivity utilised to incentivise sales for d

  11. Slide 11: Revenue Growth

    REVENUE GROWTH For personal use only 250,000 ¡ FY2021 Half-year results saw a 2,032% revenue increase 200,000 ¡ June ‘21 delivered a record quarterly Receipts from customers cashflow 150,000 ¡ Increasing number of distribution partners 100,000 ¡ Increasing application of product to new markets 50,00

  12. Slide 12: Corporate Snapshot - One-Year Price Chart

    CORPORATE SNAPSHOT - ONE-YEAR PRICE CHART For personal use only Corporate details* Major shareholders Shares on issue 191.4m Board and management 58.3% Options on issue 7.2m Top 20 23.3% Current share price (8 Sept. 2021) $0.043 Market cap. $8.23m 52 week high - low $0.040 - $0.110 Data as at 08 Sep

  13. Slide 13: Investment Proposition

    INVESTMENT PROPOSITION For personal use only ¡ Low capital investment for new products ¡ Expanded product range year-on-year ¡ Successful commercialisation of Nanoshield™ with securing of flagship customer, Nestlé Group’s Professional Services Unit ¡ Strong network of International Distributors for

  14. Slide 14: For personal use only

    For personal use only www.nanoshield.co | www.nanoveu.com | [email protected] Nanoshield™ Is a registered Trade Mark of Nanoveu. 13

Nanoveu — Broker Briefing – Tech and Biotech Investor Webinar (September 2021) on 6ix